Opsens To Present at the LD Micro Invitational

QUEBEC CITY, QC / ACCESSWIRE / May 22, 2019 / Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’ President and Chief Executive Officer, will give the presentation and host meetings with investors on both days the event will be held.

The event will take place at the Luxe Sunset Hotel in Bel Air, California on June 4th and 5th.

LD Micro is an independent resource in the microcap space. To register and attend the event, please visit https://www.ldmicro.com/events.

Investors wishing to schedule a meeting with Louis Laflamme should contact Marie-Claude Poitras at marie-claude.poitras@opsens.com.

View Opsens’ profile on LD Micro: https://www.ldmicro.com/profile/OPS.TO.

News Compliments of ACCESSWIRE

About Opsens Inc. (www.opsens.com or www.opsensmedical.com)

Opsens focuses mainly on physiological measurements such as FFR and dPR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 60,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

Contact:

Louis Laflamme, CPA, CA, Chief Executive Officer, 418.781.0333
Robin Villeneuve, CPA, CA Chief Financial Officer, 418.781.0333

SOURCE: Opsens Inc.

View source version on accesswire.com:
https://www.accesswire.com/546180/Opsens-To-Present-at-the-LD-Micro-Invitational

user

Recent Posts

Curiteva Announces First Clinical Use of Inspire Standalone ALIF System

HUNTSVILLE, ALABAMA / ACCESS Newswire / January 9, 2026 / Curiteva, Inc., a leading technology…

2 hours ago

Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

CASTRES, France and PARIS, Jan. 9, 2026 /PRNewswire/ -- Pierre Fabre Laboratories and Iktos, a global leader…

5 hours ago

Yuwell Medical Makes Its Debut at CES 2026: AI Expands the Boundaries of Health Management

LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- From January 6 to 9, CES 2026, held in…

11 hours ago

Proximity Health Solutions and Biogen Named Finalists for the SCOPE ’26 Participant Engagement Award

STAMFORD, Conn., Jan. 8, 2026 /PRNewswire/ -- Proximity Health Solutions, in collaboration with Biogen, announces that…

17 hours ago

In HelloNation, Personal Injury Attorney Professional Joseph Miklos of Garden City, NY, Launches New Expert Website Highlighting His Work in the Community

GARDEN CITY, N.Y., Jan. 8, 2026 /PRNewswire/ -- What defines a Personal Injury Attorney Professional…

17 hours ago